Clinical trials
Completed Phase 2 Hepatitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 5 |
| 2003 | 4 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 5 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 44 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 9 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 6 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| Brii Biosciences Limited | 2 |
| Vir Biotechnology, Inc. | 2 |
| ANRS, Emerging Infectious Diseases | 1 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Arbutus Biopharma Corporation | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| Conatus Pharmaceuticals Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis | 44 |
| Hepatitis C | 16 |
| Hepatitis B | 10 |
| Hepatitis B, Chronic | 8 |
| Hepatitis C, Chronic | 6 |
| Fibrosis | 5 |
| Liver Diseases | 5 |
| Fatty Liver | 3 |
| Hepatitis, Chronic | 3 |
| Insulin Resistance | 3 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.